PCV32 COST-EFFECTIVENESS OF IRBESARTAN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION, TYPE-2 DIABETES AND RENAL DAMAGE IN MEXICO
Abstract
Authors
H Hernandez L Lepe A Gonzalez A Lemus
H Hernandez L Lepe A Gonzalez A Lemus
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now